AstraZeneca to Use Part of Russian Covid Vaccine in Trials
Pharmaceutical giant AstraZeneca's Russian branch said Friday it would use part of Russia's homemade Sputnik V vaccine in further clinical trials.
"Today we announce a clinical trial programme to assess safety and immunogenicity of a combination of AZD1222, developed by AstraZeneca and Oxford University, and Sputnik V, developed by Russian Gamaleya Research institute" AstraZeneca said in a statement published on its website in English and Russian.
Source: Agence France Presse
| Copyright © 2012 Naharnet.com. All Rights Reserved. | https://www.naharnet.com/stories/en/277558 |